Harsco Corporation (HSC)       7.5  +0.23 (+3.16%)

7.5  +0.23 (+3.16%)

US4158641070 - Common Stock - After market: 7.5 0 (0%)


Fundamental Rating

Overall HSC gets a fundamental rating of 3 out of 10. We evaluated HSC against 99 industry peers in the Commercial Services & Supplies industry. HSC has a bad profitability rating. Also its financial health evaluation is rather negative. HSC is valued quite cheap, but it does not seem to be growing.




Profitability

Profitability Rating


The profitability ratios for HSC are negative, so there is not much use analyzing them.
HSC has a Return On Assets of -1.42%. This is below the industry average of 0.85%.
HSC's Return On Equity of 2.12% is worse than the rest of the industry. The industry average Return On Equity is 9.28%. 88% of the industry peers have a better Return On Equity.

HSC's Profit Margin of -2.44% is worse than the rest of the industry. The industry average Profit Margin is 0.94%.
HSC has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for HSC.
VS Industry

ROA (-1.42%) VS Industry: 36% outperformed.

-161.32
75.84

ROE (2.12%) VS Industry: 12% outperformed.

0.00
155.73

Profit Margin (-2.44%) VS Industry: 38% outperformed.

-10,900.00
41.46

Valuation

Valuation Rating


The Price/Earnings Ratio is 10.87, which indicates a very decent valuation of HSC.
HSC's Price/Earning Ratio is a bit cheaper than the industry average which is at 17.65.
The Forward Price/Earnings Ratio of 10.67 indicates a rather cheap valuation of HSC.
HSC's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a price book ratio of 0.82, HSC is valued rather cheaply.
Compared to an average industry price book ratio of 2.03, HSC is valued rather cheaply. On top of this, HSC is cheaper than 89% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 10.26, HSC is valued rather cheaply
VS Industry

Price/Earnings (10.87) VS Industry: 72% outperformed.

270.00
1.94

Price/Book (0.82) VS Industry: 89% outperformed.

37.76
0.17

Enterprise Value/ EBITDA (8.24) VS Industry: 66% outperformed.

835.41
0.02

Growth

Growth Rating


HSC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.75%, which is quite impressive.
The Earnings Per Share has been growing by 12.11% on average over the past 5 years. This is quite good.
The Earnings Per Share is expected to grow by 4.85% on average over the next 5 years.
Measured over the past 5 years, HSC shows a small growth in Revenue. The Revenue has been growing by 4.96% on average per year.

HSC is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -2.73% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
HSC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.11%.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.11% -13.43% 43.75% -55.38% -9.08% -0.18% 4.85%
Revenue4.96% 11.11% -11.11% -9.02% -2.6% -2.85% -2.73%

Health

Health Rating


A Current Ratio of 1.50 indicates that HSC should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.50.
HSC has a Quick Ratio of 1.37. This is a normal value and indicates that HSC is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 1.26.

The Altman-Z score is in line with the industry averages, which is at 1.76.
Compared to an average industry Debt to Equity Ratio of 0.49, HSC is requires more financing than its industry peers. 87% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 1.75, we must say that HSC is in the distress zone and has some risk of bankruptcy.
The Piotroski-F score of HSC is 2.00. This is a very weak score and indicates problems in health and profitability for HSC.
VS Industry

Debt/Equity (1.97) VS Industry: 13% outperformed.

23.68
-46.53

Quick Ratio (1.37) VS Industry: 55% outperformed.

0.05
30.99

Current Ratio (1.5) VS Industry: 50% outperformed.

0.05
30.99

Altman-Z (1.75) VS Industry: 48% outperformed.

-54.60
16.55

Dividend

Dividend Rating


No dividends for HSC!.

HSC Daily chart

Harsco Corporation7.5

NYSE:HSC (6/24/2022, 7:04:00 PM)+0.23 (+3.16%)

After market: 7.5 0 (0%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Commercial Services & Supplies
Earnings (Last) 05-03 2022-05-03/bmo Earnings (Next) 08-01 2022-08-01
Ins Owners 1.36% Inst Owners 86.86%
Market Cap 595.63M Analysts 82
Valuation
PE 10.87 Fwd PE 10.67
PEG (NY) N/A PEG (5Y) 0.9
P/S 0.34 P/B 0.82
EV/EBITDA 8.24
Profitability
ROA -1.42% ROE 2.12%
PM -2.44 Asset Turnover 0.58
Growth
EPS 1Y 43.75% EPS 3Y -13.43%
EPS 5Y 12.11% EPS growth Q2Q -106.67%
EPS Next Y -55.38% EPS Next 2Y -9.08%
EPS Next 3Y -0.18% EPS Next 5Y 4.85%
Revenue growth 1Y -11.11% Revenue growth 3Y 11.11%
Revenue growth 5Y 4.96% Revenue growth Q2Q -14.39%
Revenue Next Year -9.02% Revenue Next 2Y -2.6%
Revenue Next 3Y -2.85% Revenue Next 5Y -2.73%
Health
Current Ratio 1.5 Quick Ratio 1.37
Altman-Z 1.75 F-Score 2
Debt/Equity 1.97
Dividend
Dividend Yield 0% Dividend Growth N/A
DP 0% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA